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Background: Very late diagnosis of HIV is a serious public health issue. We used 
serious incident reporting (SIR) to identify and address reasons for late diagnoses 
across the patient pathway. 
Methods: Cases of very late HIV diagnosis were reported via SIR in two 6-month 
batches between 2011-2012 in Bournemouth, Poole, and Bristol. Case notes were 
reviewed for missed opportunities for earlier diagnosis using a root-cause analysis 
tool. 
Results:  33 patients (aged 30-67 years, 66% male) were diagnosed very late. 
Although the majority were white British (n=17), Black African (n=9) and Eastern 
European (n=4) ethnicities were over-represented. 24 (73%) patients had clinical 
indicator conditions for HIV, 30 (91%) had a risk factor for HIV acquisition, with 13 
(39%) having 2 or more (men-who-have-sex-with-men (n=11), partner HIV positive 
(n=11), from high prevalence area (n=12)). Actions resulting from SIR included 
increasing awareness of indicator conditions, HIV education days within primary 
care, and initiatives to increase testing within hospital specialities. 
Conclusions:  SIR allowed identification of reasons for very late HIV diagnosis and 
provided an impetus for initiatives to address them. SIR may be part of an effective 
strategy to prevent late diagnosis of HIV which would have important benefits for 
individual and population health. 
 
 
Introduction 
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In 2012 an estimated 100,000 people were living with HIV in the UK of whom 
approximately 22% were unaware of their infection(1). Of those individuals newly 
diagnosed with HIV, 47% were diagnosed late and 1 in 4 experienced a missed 
opportunity for an earlier diagnosis within the healthcare system in the preceding 
year(2, 3). Late diagnosis of HIV is associated with increased hospitalisations, 
decreased life expectancy (4-6), and higher treatment and care costs to the National 
Health Service (NHS)(7). Importantly, individuals with undiagnosed HIV are likely to 
be responsible for the majority of transmissions because successfully treated 
individuals are unlikely to infect others(8). Public Health England is committed to 
decreasing late HIV diagnoses which requires an understanding of their causes and 
whether there are missed opportunities in either primary or secondary care for 
earlier diagnosis. 
 
Previous studies have researched correlates of late diagnosis and strategies to 
reduce late diagnosis of HIV in high prevalence areas (9). However, what is lacking is 
research on a mechanism for getting late diagnosis of HIV to be considered at a 
strategic level, and to understand how to trigger appropriate action at the local level 
based on procedures in usual clinical practice. However, there is a good system 
within secondary healthcare to notify, investigate, and influence using the serious 
incident reporting (SIR) procedure which has not previously been used to inform 
changes that might result in earlier HIV diagnosis. 
 
In 2011 the Office for Sexual Health under guidance from the South West Sexual 
Health Board established a pilot study on very late diagnosis of HIV. The sexual 
4 
 
health lead invited NHS Bournemouth and Poole, and NHS Bristol (including North 
Somerset and South Gloucester) to pilot a review of all cases of very late diagnosis of 
HIV in line with the national framework for reporting and learning from serious 
adverse incidents. These primary care trusts (PCTs) were chosen because their 
diagnosed HIV prevalence was around the threshold of 2/1000 adult population (10) 
above which National Institute for Health and Care Excellence guidelines recommend  
routinely offering HIV tests to new registrants in primary care (PC) and to people 
from high risk groups such as black Africans and men-who-have-sex-with-men 
(MSM)(11,12).  
The primary aim of the study was to pilot the use of SIR to allow a root-cause 
analysis of very late HIV diagnosis in both primary and secondary care, and to 
formulate and implement an action plan based on the causes identified.  The 
secondary aim was to qualitatively assess whether the SIR process was an effective 
catalyst for improving access to testing and preventing very late HIV diagnosis. 
Fundamentally, we wished to understand the effect of SIR across the health 
community as a public health intervention, rather than focusing on the acute setting 
where the SIR was triggered in isolation.  
METHODOLOGY  
The project was coordinated by the South West Office for Sexual Health (England) 
which established a team of clinicians, commissioners, consultants in Public Health, 
as well as academic and PC representation from NHS Bournemouth and Poole, and 
NHS Bristol. Support was sought from the NHS South of England Patient Safety Team, 
Chief Executives, Medical Directors, and Directors of Public Health in the relevant PC 
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and NHS Trusts. The Royal Bournemouth and Christchurch Hospital Genitourinary 
Medicine (GUM) Department and the North Bristol NHS Trust HIV Department 
provide care for over 800 HIV patients in the Bournemouth and Poole area, and over 
1000 HIV patients from Bristol and surrounding areas, respectively.   
 
Current UK guidelines recommend that antiretroviral therapy should be started in 
patients with a CD4 count below 350 cells/mm3(13-14). Late diagnosis of HIV is 
defined as patients with a CD4 count within 3 months of diagnosis of  <350 
cells/mm3   and very late <200cells/mm3 or with an AIDS defining condition (15-16). 
The project reported as serious incidents all cases of very late diagnosis between 
January and June 2011 in Bristol and between June and December 2011 in 
Bournemouth and Poole (Audit 1). The incidents were reported as a batch and 
submitted via the Strategic Executive Information System (StEIS) in February 2012. 
The SIR process was complied with and action plans produced. Data on a second 
batch of late diagnoses from January to June 2012 were collected at both sites and 
submitted in September 2012 (Audit 2).  
 
We developed a root-cause analysis (RCA) tool (see supplementary material) to 
determine whether patients had previously presented with risk factors or clinical 
indicators for HIV. RCA aims to identify the origin of a problem using a specific set of 
steps with associated tools to find the primary cause. The standards underpinning the 
tool were taken from the UK guidelines for HIV testing (13). In addition a protocol and 
case review template for hospital and PC data collection were also developed. Notes 
of all newly diagnosed patients were screened and patients not from the relevant 
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areas or with a CD4 count >200 cells/mm3 at diagnosis were excluded.  For each case, 
demographic characteristics, clinical indicator (CI) conditions, CD4 count, risk factors 
and prior visits to a General Practitioner (GP) or hospital were collated from the 
medical records. The patient was consented and a case review request was sent to 
their GP and/or hospital clinician as appropriate. The review assessed further 
information on the patient’s history, GPs’/clinicians’ knowledge of CI conditions, what 
steps they were taking to increase HIV testing and whether support or education was 
required.  The GUM/HIV consultant followed up all responding GPs/clinicians by letter 
with full RCA containing information and advice on recognising CIs. In December 2012 
the project group analysed the audit data and recommended interventions to prevent 
future occurrence of late diagnoses. 
 
RESULTS 
In Bournemouth and Poole during the year of the audit 46 people were newly 
diagnosed with HIV of whom 31 (67%) had a CD4 count below 350 cells/mm3 and 19 
(41%) were very late diagnoses. The corresponding figures for Bristol were: 56 new 
diagnoses of HIV, of whom 32 (57%) and 21 (38%) were late and very late diagnoses, 
respectively. Across both areas, 7/40 identified individuals were excluded from the 
audit as they either did not live in the area, had a previous positive test but had 
fallen out of treatment, or had a positive test abroad and delayed access to 
treatment until returning to the UK.   Table 1 shows the summary of characteristics 
of the 33 patients included in the two-stage audit by area. Their ages ranged from 30 
to 67 years, and 21 (66%) were male. Black African (27%) and Eastern European 
7 
 
(12%) ethnicities were over-represented compared with the background population, 
although the majority were white British (52%). Nearly all patients had at least one 
risk factor for HIV acquisition, 13 (39%) had two or more, and one three risk factors. 
Frequently identified risk factors were: MSM (n=11), partner HIV-positive (n=11), 
patient from a high prevalence area (n=7), or from sub Saharan Africa (n=5).  
 
The proportion of patients diagnosed in secondary care was very high in 
Bournemouth and Poole (14/15, 93%) and lower in Bristol (10/18, 56%). The review 
process in PC was successfully completed in 11/15 and 15/18 cases in Bournemouth 
and Poole, and Bristol, respectively. Attendance within PC in the year preceding 
diagnosis was high with many patients presenting on numerous occasions. There 
was no evidence that individuals had refused a test, although one Bristol patient 
initially refused but then agreed to test within the same care episode. A high 
proportion of patients had HIV CIs including recurrent mouth ulcers, weight loss, skin 
lesions, pneumocystis pneumonia, tuberculosis, shingles, chronic diarrhoea, 
unexplained blood dyscrasia, lymphadenopathy, oral candidiasis and STIs. The 
following case illustrates multiple missed opportunities for testing based on CI 
presentation.  The patient registered with a GP practice in 2010, was diagnosed with 
tuberculosis later that year,  and then re-presented to PC  in February 2011 with 
persistent cough, loin pain and night sweats. The patient was admitted to hospital in 
March 2011 with generalised abdominal pain, but was not diagnosed with HIV until 
March 2012.  
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As a result of the SIR and audit in Bournemouth and Poole, programmes to increase 
awareness of CIs for HIV and testing guidance were developed for use in PC. An HIV 
practice website was developed, GPs attended in-house education during practice 
meetings and education days, and a pilot testing programme was launched in a 
higher prevalence area which invited patients to test. 
  
Work was done to increase HIV testing within hospital specialties.  A campaign 
increased awareness of specific CIs within the Emergency Department. Consultants 
agreed to test patients who had any HIV CIs. This is now official policy, with posters 
of CIs displayed in all departments. Monthly HIV educational update sessions were 
held for staff at Poole Hospital with feedback of laboratory HIV positivity rates.  The 
Royal College of Emergency Medicine was successfully lobbied to change HIV testing 
recommendations. 
 
On a strategic level, measures were undertaken to ensure late diagnosis remained a 
priority within the local authority.  A sexual health commissioning intention strategy 
was agreed across commissioning and provider organisations. Increased testing was 
commissioned in core sexual health services (e.g pregnancy termination and 
community sexual health). A training plan was developed for health professionals to 
improve knowledge of CIs. A community testing programme targeting very high risk 
groups for education events and testing was established. A tendering process is 
underway to develop more integrated sexual health services and to develop 
outreach GUM clinics in high prevalence areas. Since enhanced testing was 
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introduced in Bournemouth and Poole late diagnosis has decreased from 50% to 
32%. 
 
In Bristol there was no evidence to suggest impaired access to HIV testing in 
secondary care as patients with risk factors appeared to be testing appropriately as 
part of the diagnostic process. This may be due to previous engagement of the HIV 
service with clinical teams to raise the profile of HIV testing in hospital clinics. There 
was, however, evidence of missed opportunities for testing in PC. A sexual health 
annual study day was held for practice nurses and GPs during which the audit data 
and issues relating to very late diagnosis were presented. Practices were encouraged 
to offer HIV testing at the point of registration to individuals from high prevalence 
countries. A web link and presentation slides on guidance for testing such individuals 
was made available for GPs and nurses, which resulted in requests for further 
training on HIV.  In GP and hospital settings in Bristol and Bournemouth and Poole 
testing increased by 5% and 6%, respectively, between 2012-13. 
 
   
DISCUSSION  
Main findings of this study 
Our study showed that SIR of very late HIV diagnoses in six month batches was an 
effective intervention for raising awareness across the health community. The audit 
found many missed opportunities for earlier HIV diagnosis, particularly in PC. 
Patients were accessing health services with opportunistic infections, ranging from 
0-11 times, before an HIV test was offered, supporting the need to improve 
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recognition of HIV CIs. In PC, testing was not considered even when there were 
multiple CIs for HIV because the focus was on diagnosis for individual symptoms 
which led to referral for unnecessary procedures and investigations.   Although risk 
factors were recorded in the majority of notes, they were not considered alongside 
CIs as part of a more holistic diagnosis to request an HIV test.  Failure to assess risk 
was more likely when individuals presenting were at a low perceived risk (e.g white, 
European, married) and not from the standard high risk groups.  
 
What is already known on this topic 
Our audit of very late HIV diagnosis supports previous literature on both the 
predominant modes of HIV transmission and in terms of specific groups or 
communities where late diagnoses most frequently occurs(17-18), for example, in 
older adults (19-20). HIV testing, which is free and confidential at services such as 
STI clinics, should be promoted among higher risk groups to ensure individuals are 
aware of their HIV status. MSM are recommended to have an HIV/STI screen at least 
annually, and every three months if having unprotected sex with new or casual 
partners. Black Africans and Caribbeans should have an HIV test with repeat 
screening if having unprotected sex with new or casual partners.  
 
Barriers to testing may be greater for the healthcare professionals than for patients 
(21).  Reasons for not testing include insufficient time, competing priorities, 
inadequate knowledge/training, perceived burdensome consent process and pre-
test discussion, low risk populations and fear/concern of offending the patient(22-
23). Previous studies reported the need for education and training on HIV testing for 
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GPs (24-25). Some still perceive requesting an HIV test as a specialist role that 
cannot be offered outside a specialist setting, such as GUM, despite BHIVA 
guidelines (2008) stating that no special competencies are required to consent for 
and conduct an HIV test (13).  
 
There are capacity, cost and policy implications for practices in addition to training, 
engagement and acceptance of normalising HIV testing. In 2012 the Health 
Protection Agency presented to commissioners of sexual health and HIV services the 
evidence on acceptability, feasibility, clinical benefit and cost-effectiveness of 
expanding HIV testing in general medical admissions and new registrants in general 
practice. The routine offer of an HIV test was shown to be acceptable to patients 
and feasible in a variety of medical settings (9). The key to earlier diagnosis is to 
normalise testing within a range of groups (26). In higher prevalence settings, opt-
out (27)  and routine HIV testing strategies have been advocated in PC (28) which 
are less stigmatising and therefore more acceptable to high risk groups(27,29). 
Although routine, not targeted, testing was often the commonest reason for people 
accessing testing(30-31), targeted testing may be more appropriate in lower 
prevalence settings.  
 
What this study adds 
Two key aspects of our study were submitting data in batches to provide sufficient 
cases to compare and identify trends, and recognising that the SIR process should 
relate to the entire patient pathway and involve the whole health community. 
Unlike audit which focuses on one aspect of the NHS, the SIR process allowed 
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organisational responsibility for very late HIV diagnosis to be correctly apportioned 
across the NHS.  In addition, SIR facilitated systematic review of cases to improve 
detection and consideration of the issue at a senior level within organisations 
thereby informing population testing strategies. 
 
This pilot was undertaken at a time of significant change to health systems in the UK 
and was seen as an opportunity to influence NHS England and the Clinical 
Commissioning Groups (CCG) established after April 2013, which are responsible for 
PC. The responsibility for local public health previously based in PCTs was 
transferred to local authorities, which are now responsible for commissioning HIV 
testing in community settings. Presentations of this audit in a range of settings and 
the importance placed on SIR made the case for the need to commission improved 
HIV testing opportunities. Highlighting the issues surrounding very late diagnosis 
and the timely multi-agency drive for education on CIs and testing gave healthcare 
staff access to training, support and updated HIV testing pathways. This support was 
disseminated to all GPs across Dorset and community sexual health staff through 
sexual health strategic and delivery groups to encourage engagement and 
motivation.  
 
In Bristol, missed opportunities for testing were apparent in primary, but not 
secondary care. GPs were encouraged to offer tests to new registrants from high 
prevalence countries. However, completion of the full SIR process was disrupted 
due to the coincidence of timing of the 2013 NHS reorganisation and associated 
changes in commissioning structure.  
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Limitations 
Our study was a pilot and therefore numbers of new diagnoses during the study 
period were only just over 100. The audit was restricted to two centres in SW 
England, but may be generalizable to medium prevalence cities elsewhere in the UK, 
particularly those with higher levels of late diagnoses than the national average. The 
audit revealed that, due to the way screening information is collected on GP 
systems, there was limited documented evidence of when a test had been offered or 
refused. These data are critical for determining which interventions would be 
effective in reducing late diagnosis. Dates of diagnosis of CI conditions were not 
recorded in this study, but could be used to evaluate the economic and clinical 
impact of delay in diagnosis from the first missed opportunity. This pilot study only 
followed up individuals diagnosed with very advanced HIV disease, but SIR could  be 
extended to include those with a late diagnosis of HIV ( CD4 <350cells/mm3 at 
presentation) as this cohort  also requires  investigation.  
 
Conclusions and Recommendations 
Increased testing in PC needs to be a commissioning priority. Screening new 
registrants particularly for people from high prevalence areas and opt-out testing 
should be considered in higher prevalence practices. This would normalise HIV 
testing, remove stigma, and increase access. There needs to be a change in cultural 
practice beliefs that HIV awareness and testing is a specialist role that cannot be 
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offered outside a specialist setting. Barriers to testing must be addressed to ensure 
patients receive a prompt and early diagnosis of HIV.  
 
Key messages are that many opportunities, particularly in PC, are missed for earlier 
HIV diagnosis and that documentation of HIV testing needs improving. HIV testing 
should be added to the GP system with date of test offer, and whether an HIV test 
was given or refused. Support at national level is required to improve recording in 
PC. Health professionals require ongoing education in recognising HIV CI  conditions 
and risk factors for HIV acquisition(32-33). SIR provides a mechanism to investigate 
very late diagnosis and use the information to influence practice in PC and other 
specialties, and could change testing strategies across the health community. 
Although reporting cases of late diagnosis increases the workload, it does have a 
crucial effect on relaying issues to other sectors.  Furthermore, late diagnosis is 
proportionally less in areas of high prevalence due to greater awareness of the 
likelihood of HIV (1). 
 Late HIV diagnosis should continue to be monitored and SIR considered in other 
regions wanting to reduce late and very late diagnosis of HIV.  
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